Vaccine Development
From concept to clinical trials: innovative vaccine platforms, formulation strategies, and accelerated development pathways.
Speaker profile
Conference homeSessions
A curated scientific program featuring parallel sessions across vaccine development, immunology, clinical trials, and global health. The agenda includes keynote lectures, expert discussions, poster presentations, and interactive workshops designed to advance vaccine science.
The conference will be organized around thematic tracks, reflecting the main focus areas of vaccine science, immunology, and clinical advancement. These tracks encourage participants to explore their topic in depth while exploring interdisciplinary questions from vaccine development to public health implementation.
From concept to clinical trials: innovative vaccine platforms, formulation strategies, and accelerated development pathways.
Understanding T-cell and B-cell responses, mucosal immunity, and immunological mechanisms driving vaccine efficacy.
Cutting-edge mRNA technology, viral vectors, protein subunits, and novel vaccine platforms for infectious and non-infectious diseases.
Phase I-IV trial design, efficacy assessment, immunogenicity studies, and adaptive trial strategies.
Pharmacovigilance, adverse event monitoring, post-market surveillance, and safety data integration.
Public health implementation, accessibility, equity, vaccine hesitancy, and global health policy.
Machine learning for antigen design, immunoinformatics, predictive modeling, and data-driven vaccine development.
GMP manufacturing, scale-up strategies, quality assurance, and cost-effective production technologies.
The list of topics covers current and emerging research in vaccine science, immunology, infectious disease prevention, and clinical advancement: from laboratory innovation to population health.
Program sessions include keynote lectures, oral presentations, poster sessions, and interactive workshops, fostering knowledge exchange, collaboration, and scientific discovery.
Vision-setting talks from world-leading vaccine researchers and immunologists, framing breakthrough discoveries and future directions for the full audience.
Peer-reviewed vaccine research presented as short talks within parallel scientific tracks and specialty sessions.
Dedicated viewing hours with authors present for in-depth discussion and structured scientific networking.
Multi-stakeholder debates on vaccine policy, clinical evidence, public health implementation, and research gaps.
Interactive small-group sessions focused on trial design methods, immunoassays, manufacturing, and emerging vaccine technologies.
Mentored presentations and rapid-fire talks showcasing groundbreaking early-career vaccine research.
Visit CVIC 2027 in San Diego, California and connect with global vaccine innovators, immunologists, and public health leaders over a transformative two-day conference.